{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:38:38Z","timestamp":1790005118820,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This ecological study examines epidemiological trends in tuberculosis, multidrug-resistant TB, extensively drug-resistant TB, and latent TB infection across Iran and its provinces from 1990 to 2021, and explores their association with the Human Development Index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Data from the Global Burden of Disease 2021 study, were used to assess the incidence, mortality, and prevalence of tuberculosis, multidrug-resistant tuberculosis, extensively drug-resistant tuberculosis, and latent tuberculosis infection at both national and provincial levels in Iran. The association between tuberculosis indicators and the Human Development Index was evaluated using bivariate correlation analysis, with\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05 considered statistically significant. Geographic maps illustrating the spatial distribution of the disease across provinces were generated using Arc-GIS 10.8.2 software. All statistical analyses were performed using Stata version 12 (Stata Corp, College Station, TX, USA).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The age-standardized incidence rate (ASIR) of tuberculosis decreased from 22.60 cases per 100,000 population (95% CI: 20.09\u201325.41) in 1990 to 13.51 cases (95% CI: 11.98\u201315.15) in 2021. The average annual percent change was: \u2212\u20090.40 (95% CI: \u2212\u20090.43 to \u2212\u20090.37). In 2021, the age-standardized mortality rate was 1.09 cases per 100,000 (95% CI: 0.92\u20131.30), with an average annual percent change: \u2212\u20090.73; (95% CI: \u2212\u20090.80 to \u2212\u20090.57). Sistan and Baluchistan (32.21 per 100,000) and Golestan (24.46 per 100,000) reported the highest incidence rates, whereas Chahar Mahaal and Bakhtiari (3.08 per 100,000) and Isfahan (6.71 per 100,000) reported the lowest. A significant inverse correlation was observed between the Human Development Index and tuberculosis indicators (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). The prevalence of multidrug-resistant tuberculosis was 1.7%, and the prevalence of latent tuberculosis infection was 25,027 cases per 100,000 population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Substantial progress has been made in reducing the tuberculosis burden in Iran. Nevertheless, marked regional disparities and persistent challenges related to multidrug-resistant tuberculosis and latent TB infection highlight the need for targeted interventions, including enhanced screening, improved diagnostic capacity, and expanded preventive treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13148-2","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:07:17Z","timestamp":1775909237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The epidemiology of tuberculosis infection and the Human Development Index (HDI) in Iran between 1990\u20132021: secondary analysis of the global burden of disease"],"prefix":"10.1186","volume":"26","author":[{"given":"Afsaneh","family":"Kaffash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeideh Sadat","family":"Shobeiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Pouraslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asghar","family":"Kazemzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Doost","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Ghazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Ashena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaher","family":"Khazaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"issue":"04","key":"13148_CR1","first-page":"79","volume":"13","author":"S-X Zhang","year":"2024","unstructured":"Zhang S-X, et al. Epidemiological features and temporal trends of the co-infection between HIV and tuberculosis, 1990\u20132021: findings from the Global Burden of Disease Study 2021. Infect Dis poverty. 2024;13(04):79\u201394.","journal-title":"Infect Dis poverty"},{"issue":"1","key":"13148_CR2","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1186\/s12889-024-20664-w","volume":"24","author":"H Yang","year":"2024","unstructured":"Yang H, et al. Global, regional, and national burden of tuberculosis and attributable risk factors for 204 countries and territories, 1990\u20132021: A systematic analysis for the Global Burden of Diseases 2021 study. BMC Public Health. 2024;24(1):3111.","journal-title":"BMC Public Health"},{"key":"13148_CR3","doi-asserted-by":"publisher","first-page":"100595","DOI":"10.1016\/j.ijregi.2025.100595","volume":"14","author":"A Al Maani","year":"2025","unstructured":"Al Maani A, Petersen E, Memish ZA. The critical role of new tuberculosis vaccines in achieving the WHO 2035 End TB target. IJID Reg. 2025;14:100595.","journal-title":"IJID Reg"},{"issue":"6","key":"13148_CR4","first-page":"73","volume":"8","author":"L Chunrong","year":"2023","unstructured":"Chunrong L, et al. 2023 WHO Tuberculosis Report: key data analysis for China and the global world. Electron J Emerg Infect Dis. 2023;8(6):73.","journal-title":"Electron J Emerg Infect Dis"},{"issue":"1","key":"13148_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40249-024-01227-y","volume":"13","author":"S-X Zhang","year":"2024","unstructured":"Zhang S-X, et al. Global, regional, and National burden of HIV-negative tuberculosis, 1990\u20132021: findings from the global burden of disease study 2021. Infect Dis Poverty. 2024;13(1):60.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"13148_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.18176\/resp.00028","volume":"23","author":"P Godoy","year":"2021","unstructured":"Godoy P. Guidelines on controlling latent tuberculosis infection to support tuberculosis elimination. Revista Espa\u00f1ola de Sanidad Penitenciaria. 2021;23(1):28.","journal-title":"Revista Espa\u00f1ola de Sanidad Penitenciaria"},{"key":"13148_CR7","doi-asserted-by":"publisher","first-page":"943545","DOI":"10.3389\/fcimb.2022.943545","volume":"12","author":"D Liebenberg","year":"2022","unstructured":"Liebenberg D, Gordhan BG, Kana BD. Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management. Front Cell Infect Microbiol. 2022;12:943545.","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"13148_CR8","doi-asserted-by":"publisher","first-page":"e559","DOI":"10.1016\/S1473-3099(24)00144-0","volume":"24","author":"K Naidoo","year":"2024","unstructured":"Naidoo K, et al. The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis\u2014lessons from the South African experience. Lancet Infect Dis. 2024;24(9):e559\u201375.","journal-title":"Lancet Infect Dis"},{"key":"13148_CR9","doi-asserted-by":"publisher","first-page":"1487518","DOI":"10.3389\/ftubr.2024.1487518","volume":"2","author":"B Gilmour","year":"2024","unstructured":"Gilmour B, Alene KA. Ending tuberculosis: Challenges and opportunities. Front Tuberculosis. 2024;2:1487518.","journal-title":"Front Tuberculosis"},{"issue":"1","key":"13148_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12889-023-15213-w","volume":"23","author":"FA K\u00f6ltringer","year":"2023","unstructured":"K\u00f6ltringer FA, et al. The social determinants of national tuberculosis incidence rates in 116 countries: a longitudinal ecological study between 2005\u20132015. BMC Public Health. 2023;23(1):337.","journal-title":"BMC Public Health"},{"issue":"6","key":"13148_CR11","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.18203\/2320-6012.ijrms20241585","volume":"12","author":"M Okram","year":"2024","unstructured":"Okram M, Singh OM. Tuberculosis: A narrative review on epidemiology, risks, implications, preventions and treatments. Int J Res Med Sci. 2024;12(6):2172.","journal-title":"Int J Res Med Sci"},{"key":"13148_CR12","doi-asserted-by":"crossref","unstructured":"Matteelli A, et al. Update on multidrug-resistant tuberculosis preventive therapy toward the global tuberculosis elimination. Int J Infect Dis. 2025;155.","DOI":"10.1016\/j.ijid.2025.107849"},{"key":"13148_CR13","doi-asserted-by":"publisher","first-page":"1438406","DOI":"10.3389\/ftubr.2024.1438406","volume":"2","author":"I Kudryavtsev","year":"2024","unstructured":"Kudryavtsev I, et al. The role of the immune response in developing tuberculosis infection: from latent infection to active tuberculosis. Front Tuberculosis. 2024;2:1438406.","journal-title":"Front Tuberculosis"},{"issue":"8","key":"13148_CR14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S2213-2600(24)00083-3","volume":"12","author":"L Martinez","year":"2024","unstructured":"Martinez L, et al. Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies. Lancet Respiratory Med. 2024;12(8):633\u201341.","journal-title":"Lancet Respiratory Med"},{"key":"13148_CR15","unstructured":"Clark RA. Mathematical modelling of the impact of adolescent\/adult tuberculosis vaccines to inform global, national, and subnational policy and delivery. London School of Hygiene & Tropical Medicine; 2023."},{"issue":"9","key":"13148_CR16","doi-asserted-by":"publisher","first-page":"e3468","DOI":"10.1093\/cid\/ciaa1662","volume":"73","author":"JM Collins","year":"2021","unstructured":"Collins JM, et al. Prevalence of latent tuberculosis infection among non-US-born persons by country of birth\u2014United States, 2012\u20132017. Clin Infect Dis. 2021;73(9):e3468\u201375.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"13148_CR17","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1186\/s12889-023-17114-4","volume":"23","author":"H Fallahzadeh","year":"2023","unstructured":"Fallahzadeh H, et al. Distribution incidence, mortality of tuberculosis and human development index in Iran: estimates from the global burden of disease study 2019. BMC Public Health. 2023;23(1):2404.","journal-title":"BMC Public Health"},{"issue":"40","key":"13148_CR18","first-page":"153","volume":"18","author":"Z Negintaji","year":"2024","unstructured":"Negintaji Z, Esmailinia S. Calculation of the Economic Globalization Index in Iran and its Impact on Human Development Index (HDI). Macroeconomics Res Letter. 2024;18(40):153\u201377.","journal-title":"Macroeconomics Res Letter"},{"issue":"4","key":"13148_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/computation10040064","volume":"10","author":"F Mariani","year":"2022","unstructured":"Mariani F, Ciommi M. Aggregating composite indicators through the geometric mean: A penalization approach. Computation. 2022;10(4):64.","journal-title":"Computation"},{"key":"13148_CR20","doi-asserted-by":"crossref","unstructured":"Mehmetoglu M, Jakobsen TG. Applied statistics using Stata: a guide for the social sciences. Sage; 2022.","DOI":"10.4135\/9781036231446"},{"key":"13148_CR21","doi-asserted-by":"crossref","unstructured":"Khazaei Z, et al. Global incidence and mortality of esophageal cancer and its relationship with the Human Development Index (HDI); An Ecology Study. Asian Pac J Cancer Nurs, 2019: pp. 20191111\u201320191111.","DOI":"10.31557\/apjcn.1656.20191111"},{"issue":"1","key":"13148_CR22","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1186\/s12879-025-11566-2","volume":"25","author":"E-L Tan","year":"2025","unstructured":"Tan E-L, et al. Global burden of MDR-TB and XDR-TB: trends, inequities, and future implications for public health planning. BMC Infect Dis. 2025;25(1):1225.","journal-title":"BMC Infect Dis"},{"key":"13148_CR23","doi-asserted-by":"publisher","first-page":"1408316","DOI":"10.3389\/fpubh.2024.1408316","volume":"12","author":"H-W Song","year":"2024","unstructured":"Song H-W, et al. Tracking multidrug resistant tuberculosis: a 30-year analysis of global, regional, and national trends. Front Public Health. 2024;12:1408316.","journal-title":"Front Public Health"},{"issue":"1","key":"13148_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12889-025-21608-8","volume":"25","author":"SA Alinaghian","year":"2025","unstructured":"Alinaghian SA, et al. Burden of type 2 diabetes and its relationship with human development index in Asian countries: Global Burden of Disease Study in 2019. BMC Public Health. 2025;25(1):402.","journal-title":"BMC Public Health"},{"key":"13148_CR25","doi-asserted-by":"crossref","unstructured":"Khazaei Z et al. Disability-adjusted life years of Hepatitis B in Iran during 2009\u20132019: an analysis based on the global burden of Disease Study 2019. Open Public Health J. 2024;17(1).","DOI":"10.2174\/0118749445264784240223044655"},{"key":"13148_CR26","doi-asserted-by":"publisher","first-page":"1596579","DOI":"10.3389\/fmed.2025.1596579","volume":"12","author":"A Elbehiry","year":"2025","unstructured":"Elbehiry A, et al. Advancing the fight against tuberculosis: integrating innovation and public health in diagnosis, treatment, vaccine development, and implementation science. Front Med. 2025;12:1596579.","journal-title":"Front Med"},{"issue":"1","key":"13148_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12889-023-17495-6","volume":"24","author":"W Bai","year":"2024","unstructured":"Bai W, Ameyaw EK. Global, regional and national trends in tuberculosis incidence and main risk factors: a study using data from 2000 to 2021. BMC Public Health. 2024;24(1):12.","journal-title":"BMC Public Health"},{"key":"13148_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4103\/ijpvm.ijpvm_346_23","volume":"15","author":"M Rastegar","year":"2024","unstructured":"Rastegar M, et al. Spatial Distribution of Smear-Positive Pulmonary Tuberculosis Incidence Rates in Iran: A Registry-Based Study (2018\u20132022). Int J Prev Med. 2024;15:35.","journal-title":"Int J Prev Med"},{"key":"13148_CR29","unstructured":"Khazaei S, Mansournia AE, Rafiemanesh MA. H., Trend of some Tuberculosis Indices in Iran during 25 year Period (1990\u20132014). J Res Health Sci. 2016 Summer. 16(3): pp. 141\u20136."},{"issue":"1","key":"13148_CR30","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1186\/s12889-021-11157-1","volume":"21","author":"B Kiani","year":"2021","unstructured":"Kiani B, et al. Spatio-temporal epidemiology of the tuberculosis incidence rate in Iran 2008 to 2018. BMC Public Health. 2021;21(1):1093.","journal-title":"BMC Public Health"},{"key":"13148_CR31","doi-asserted-by":"crossref","unstructured":"Ammari L, et al. Epidemiology of tuberculosis, in Imaging of Tuberculosis. Springer; 2022. pp. 1\u201313.","DOI":"10.1007\/978-3-031-07040-2_1"},{"key":"13148_CR32","first-page":"13","volume":"35","author":"M Khajedaluee","year":"2021","unstructured":"Khajedaluee M, et al. The burden of tuberculosis in Iran, A 12-year population-based study. Med J Islamic Repub Iran. 2021;35:13.","journal-title":"Med J Islamic Repub Iran"},{"issue":"2","key":"13148_CR33","first-page":"149","volume":"42","author":"A Sabermahani","year":"2013","unstructured":"Sabermahani A, et al. Provincial human development index, a guide for efficiency level analysis: the case of Iran. Iran J public health. 2013;42(2):149.","journal-title":"Iran J public health"},{"issue":"3","key":"13148_CR34","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s11205-023-03230-6","volume":"170","author":"S Morse","year":"2023","unstructured":"Morse S. Quality of life, well-being and the human development index: a media narrative for the developed world? Soc Indic Res. 2023;170(3):1035\u201358.","journal-title":"Soc Indic Res"},{"issue":"1","key":"13148_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1057\/s41271-024-00543-9","volume":"46","author":"DM Fujita","year":"2025","unstructured":"Fujita DM, Alvarenga RF, de Andrade HF Jr. Trends in tuberculosis and inequality-adjusted Human Development Index in Brazil, 2018\u20132022. J Public Health Policy. 2025;46(1):139\u201348.","journal-title":"J Public Health Policy"},{"issue":"9","key":"13148_CR36","doi-asserted-by":"publisher","first-page":"e704","DOI":"10.1016\/j.ijid.2012.04.011","volume":"16","author":"AJ Rodr\u00edguez-Morales","year":"2012","unstructured":"Rodr\u00edguez-Morales AJ, Casta\u00f1eda-Hern\u00e1ndez DM. Relationships between morbidity and mortality from tuberculosis and the human development index (HDI) in Venezuela, 1998\u20132008. Int J Infect Dis. 2012;16(9):e704\u20135.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"13148_CR37","first-page":"710","volume":"14","author":"F Fathollahi","year":"2023","unstructured":"Fathollahi F, et al. Burden of prostate cancer and relationship with the human development index (HDI) in Asia: A study of Global Burden disease in 2019. Caspian J Intern Med. 2023;14(4):710.","journal-title":"Caspian J Intern Med"},{"key":"13148_CR38","doi-asserted-by":"publisher","first-page":"766362","DOI":"10.3389\/fpubh.2021.766362","volume":"9","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, et al. An ecological study of tuberculosis incidence in China, from 2002 to 2018. Front Public Health. 2022;9:766362.","journal-title":"Front Public Health"},{"key":"13148_CR39","doi-asserted-by":"publisher","first-page":"1512514","DOI":"10.3389\/fpubh.2025.1512514","volume":"13","author":"Z Chen","year":"2025","unstructured":"Chen Z, et al. Age-period-cohort analysis and prediction of tuberculosis trends in China\u2014based on the Global Burden of Disease 2021 data. Front Public Health. 2025;13:1512514.","journal-title":"Front Public Health"},{"issue":"1","key":"13148_CR40","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1186\/s12879-025-11439-8","volume":"25","author":"S Daneshi","year":"2025","unstructured":"Daneshi S, et al. Prevalence and contributing factors of drug-resistant tuberculosis (DR-TB) in iran: a systematic review. BMC Infect Dis. 2025;25(1):1004.","journal-title":"BMC Infect Dis"},{"key":"13148_CR41","doi-asserted-by":"publisher","first-page":"p100118","DOI":"10.1016\/j.gloepi.2023.100118","volume":"6","author":"SM Alavi","year":"2023","unstructured":"Alavi SM, et al. Incidence trend analysis of tuberculosis in Khuzestan Province, southwest of Iran: 2010\u20132019. Global Epidemiol. 2023;6:p100118.","journal-title":"Global Epidemiol"},{"issue":"4","key":"13148_CR42","doi-asserted-by":"publisher","first-page":"e00633","DOI":"10.34172\/jrhs.2024.168","volume":"24","author":"M Rastegar","year":"2024","unstructured":"Rastegar M, et al. Effective Reproduction Number of Smear-Positive Pulmonary Tuberculosis in Iran: A Registry-Based Study (2011\u20132021). J Res Health Sci. 2024;24(4):e00633.","journal-title":"J Res Health Sci"},{"issue":"1","key":"13148_CR43","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1186\/s12879-024-09947-0","volume":"24","author":"MJ Fallahi","year":"2024","unstructured":"Fallahi MJ, et al. Changes in incidence and clinical features of tuberculosis with regard to the COVID-19 outbreak in Southern Iran. BMC Infect Dis. 2024;24(1):1043.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"13148_CR44","doi-asserted-by":"publisher","first-page":"320","DOI":"10.4103\/ijmy.ijmy_162_24","volume":"13","author":"S Ayoubi","year":"2024","unstructured":"Ayoubi S, et al. Prevalence and temporal trends of multidrug-resistant tuberculosis in Iran from 1981 to 2023: a systematic review and meta-analysis. Int J Mycobacteriology. 2024;13(3):320\u201330.","journal-title":"Int J Mycobacteriology"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13148-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13148-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13148-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:50:51Z","timestamp":1781646651000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13148-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13148"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13148-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted under the auspices of Sabzevar University of Medical Sciences, with ethical approval (IR.MEDSAB.REC.1404.172).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"is not applicable to this study because it is based on publicly available, anonymized data from the Global Burden of Disease (GBD) database, which does not involve direct human subject participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"995"}}